News About: Pharm. Industry
New product license for pain killers top 265 last year
Domestic drug makers are still keen on the development of antipyretics, analgesics and anti-inflammatory agents (therapeutic category number: 114), even in midst of steep decline in newly approved medicines due to imp...
LG joins hands with Macrogen to boost cooperation in theranostics
LG Life Sciences signed a memorandum of understanding with genomic services provider Macrogen on August 3 announcing that it will engage in the genome sequencing business based on the research of theranostics.
Ther...
Drug orders through internet up
Leading pharmaceutical firms have changed their order receipt patterns to internet homepage, when pharmaceutical wholesalers place orders with over-the-counter drugs.
The move is primarily aimed at reducing the lab...
US FDA approves Huons physiological saline
Huons Co. said it has received approval from the U.S. Food and Drug Administration to export its cGMP based physiological saline.
The company said the approved ampoule-type saline has been produced from its newly c...
Once-monthly treatment for diabetes shows promise
A new diabetic medicine developed by a Korean drug maker has been under the first phase of clinical trials in the Netherlands and Korea.
The drug (codename: HM11260C), developed by Hanmi Pharmaceutical, a novel GLP...
KFDA approves Effient, blood-thinning medication
The Korea Food and Drug Administration approved a blood-thinning drug Effient tablets (prasugrel), co-developed by Eli-Lilly and Daiich Sankyo, on July 29 to reduce the risk of blood clots from forming in patients who...
Korea to develop protein based medicines
The government plans to develop a set of premier materials such as protein based drugs, which it expects will become the norms of the global markets in the not-so-distant future.
The Ministry of Knowledge Economy (...
Vaccines make Green Cross No. 4 drugmaker
Green Cross became the fourth-biggest drug manufacturer in Korea in terms of quarterly revenue, as the outbreak of Influenza A boosted overseas demand for seasonal flu vaccines.
Green Cross posted revenues of 160 ...
Government Oks sale of locally-produced hemophilia A treatment
Korea’s health authorities gave the green light to Green Cross Corp. on August 30 to sell Greengene-F injection, an albumin-free, B-domain deleted (BDD) recombinant human coagulation factor VIIIB domain VIII.
It is...
Hanmi Pharm shares boosted by simplified corporate structure
Shares of Hanmi Pharm were boosted on August 30 by expectations that it split into holding and operating entities to simplify its corporate structure.
Hanmi Pharm shares rose 11 percent to 99,900 won on the Seoul b...
